CompuGroup Medical SE & Co. KGaA

BATS-CHIXE:COPD Stock Report

Market Cap: €1.2b

CompuGroup Medical SE KGaA Management

Management criteria checks 2/4

CompuGroup Medical SE KGaA's CEO is Daniel Gotthardt, appointed in Sep 2024, has a tenure of less than a year. total yearly compensation is €4.19M, comprised of 5.6% salary and 94.4% bonuses, including company stock and options. directly owns 6.92% of the company’s shares, worth €81.52M. The average tenure of the management team and the board of directors is 2.3 years and 4.2 years respectively.

Key information

Daniel Gotthardt

Chief executive officer

€4.2m

Total compensation

CEO salary percentage5.6%
CEO tenureless than a year
CEO ownership6.9%
Management average tenure2.3yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Daniel Gotthardt's remuneration changed compared to CompuGroup Medical SE KGaA's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024€4m€233k

€35m

Sep 30 2024n/an/a

€25m

Jun 30 2024n/an/a

€32m

Mar 31 2024n/an/a

€50m

Dec 31 2023n/an/a

€46m

Sep 30 2023n/an/a

€76m

Jun 30 2023n/an/a

€89m

Mar 31 2023n/an/a

€70m

Dec 31 2022n/an/a

€73m

Sep 30 2022n/an/a

€72m

Jun 30 2022n/an/a

€71m

Mar 31 2022n/an/a

€76m

Dec 31 2021n/an/a

€69m

Sep 30 2021n/an/a

€66m

Jun 30 2021n/an/a

€72m

Mar 31 2021n/an/a

€71m

Dec 31 2020n/an/a

€73m

Sep 30 2020n/an/a

€77m

Jun 30 2020n/an/a

€60m

Mar 31 2020n/an/a

€58m

Dec 31 2019€60kn/a

€66m

Compensation vs Market: Daniel's total compensation ($USD4.58M) is above average for companies of similar size in the UK market ($USD2.47M).

Compensation vs Earnings: Daniel's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Daniel Gotthardt (51 yo)

less than a year

Tenure

€4,187,000

Compensation

Prof. (apl.) Dr. med. Daniel Gotthardt is MD & CEO of CompuGroup Medical SE & Co. KGaA since September 1, 2024 and had been its Chief Medical Officer since 2023 until September 2024 and was its Senior Vice...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Gotthardt
MD & CEOless than a year€4.19m6.92%
€ 81.5m
Daniela Hommel
MD, CFO & Member of Management Board1.1yrs€2.58mno data
Hannes Reichl
MD of Impatient & Social Care and Member of the Management Board6.3yrs€881.00k0.0077%
€ 91.1k
Emanuele Mugnani
MD of Ambulatory Information Systems Europe & Member of Management Board3.3yrs€602.00k0.0014%
€ 15.9k
Ulrich Thome
MD of Ambulatory Information Systems DACH & Member of the Management Board1.3yrs€568.00k0.00057%
€ 6.7k
Claudia Thomé
Corporate Vice President of Investor Relationsno datano datano data
Helge Weiß
Senior Vice President of Connectivity5.1yrsno datano data

2.3yrs

Average Tenure

50.5yo

Average Age

Experienced Management: COPD's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Philipp von Ilberg
Chairman of Supervisory Board4.8yrs€100.00kno data
Dierk Heimann
Member of Medical Advisory Boardno datano datano data
Ulrike Handel
Independent Member of Supervisory Board4.8yrs€50.00kno data
Bettina Volkens
Member of Supervisory Board4.8yrs€40.00kno data
Matthias Stormer
Member of Supervisory Board4.8yrs€60.00k0.0025%
€ 29.6k
Martin Kohrmann
Member of Supervisory Board4.8yrs€40.00k0.015%
€ 182.2k
Ayfer Basal
Employee Representative Member of Supervisory Board3.5yrs€50.00kno data
Adelheid Hegemann
Employee Representative Member of Supervisory Board3.5yrs€40.00k0.000070%
€ 825.0
Frank Betz
Employee Representative Member of Supervisory Board3.5yrs€50.00kno data
Stefan Weinmann
Vice Chairman of the Supervisory Board3.5yrs€60.00k0.000050%
€ 589.3
Julia Mole
Employee Representative Member of Supervisory Board4.2yrs€40.00kno data
Reinhard Lyhs
Member of Supervisory Board2yrs€40.00k0.00039%
€ 4.6k

4.2yrs

Average Tenure

57yo

Average Age

Experienced Board: COPD's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/18 11:48
End of Day Share Price 2024/12/23 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CompuGroup Medical SE & Co. KGaA is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Knut WollerBaader Helvea Equity Research
Wolfgang SpechtBerenberg
Gregory RamirezBryan Garnier & Co